Navigation Links
Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals
Date:12/10/2008

SAN FRANCISCO, Dec. 10 /PRNewswire/ -- Napo Pharmaceuticals, Inc. ("Napo") is pleased to announce a collaboration with Salix Pharmaceuticals, Inc. ("Salix") for the license of crofelemer for all indications in North America, Europe (excluding certain smaller countries), and Japan, and certain indications worldwide. Crofelemer is Napo's novel anti-secretory, gastrointestinal agent currently in a final Phase 3 trial for the treatment of chronic diarrhea in people living with HIV/AIDS (the "ADVENT" program) under fast-track status and Special Protocol Assessment agreement with the FDA. This is the first indication targeted for approval and commercialization, with a market opportunity in the US of approximately $300 million.

The terms of the deal include an up-front license fee for the crofelemer intellectual property of $4.5 mm and an equity investment of $500,000 for the purchase of 250,000 shares of Napo common stock; as well as regulatory and sales milestone(s) payments tailored to the significance of the indication and performance of the product; and tiered royalty rates ascending to a $400 million annual sales threshold. The terms provide for full funding by Salix of the on-going ADVENT program, some of which costs will be off-set against future milestone payments to Napo.

Salix, a leading U.S. specialty pharmaceutical company focusing on products to treat gastro-intestinal disorders, will have the commercialization rights to an agent with potential application -- to a broad range of indications. Crofelemer is currently in clinical development for three additional indications: adult acute infectious diarrhea, including cholera -- in Phase 2; irritable bowel syndrome (IBS) -- in Phase 2; and pediatric diarrhea -- in Phase 1.

The FDA has granted fast-track status to crofelemer for the indications of chronic diarrhea in people living with HIV/AIDS and IBS. Positive clinical data in the treatment
'/>"/>

SOURCE Napo Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Scottsdale, Ariz (PRWEB) July 28, 2014 ... closed on a new camp property in Cornville, ... provides seriously ill children with the opportunity to ... the campers and families. The organization offers a ... ages 6-15 with chronic and life threatening illnesses ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Dawn ... including sales, finance, and music. This experience has ... the direction of psychology. Her professional counseling ( ... and court-ordered treatment for offenders in domestic violence. ... Dawning Phoenix, LLC, she enjoys counseling individuals and ...
(Date:7/28/2014)... Thousands of DePuy Pinnacle hip lawsuits ... who were allegedly injured by a metal-on-metal version of ... in U.S. District Court, Northern District of Texas, Bernstein ... July 18, 2014, U.S. District Judge Ed Kinkeade has ... Steering Committee that sought the deposition of a witness ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July ... are at risk of contracting meningitis because of specific ... to updated recommendations from the largest pediatrician group in ... the potentially deadly infection should continue for adolescents and ... In its first statement on meningococcal vaccines since 2011, ...
(Date:7/28/2014)... divide unless there is enough oxygen present to support ... types circumvent this rule. Researchers at The Johns Hopkins ... cells, warning signals, enabling cancers to continue to divide ... the researchers found that lysosomes the cell,s protein ... also uncovered new evidence that certain drugs can halt ...
Breaking Medicine News(10 mins):Health News:Camp Soaring Eagle Announces New Camp Site 2Health News:Camp Soaring Eagle Announces New Camp Site 3Health News:Dawn M. Echols, M.S., LPC of Dawning Phoenix Speaks at Newly Formed Task Force 2Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 4Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 2Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 3Health News:Cell's recycling center implicated in division decisions 2
... DALLAS, Feb. 19 Cholesterol-lowering statins, used by ... may falsely indicate thyroid problems, according to researchers ... studies, low serum TSH, and the influence of ... ."These findings could help physicians make quicker, more ...
... experts say , , THURSDAY, Feb. 19 (HealthDay News) -- A ... people with type 2 diabetes, according to a study that ... sites in Canada and the United States. , The participants, ... in diabetes, underwent cognitive tests designed to measure several aspects ...
... EAST PROVIDENCE, R.I., Feb. 19 IlluminOss ... IlluminOss(TM) Photodynamic Bone Stabilization System for orthopedic surgery, today ... Bone Stabilization System had been performed on a 21 ... metacarpal.With traditional methods of treating fractures, often an incision ...
... Association and nation,s largest animal protection group say taxing ... for pet owners, increased pet abandonment and public health ... California Veterinary Medical Association (CVMA) and The Humane Society ... the California Legislature for responding to the public,s opposition ...
... Kovalic & Timothy Ogata Join Leading Private Telemedicine ... Call, Inc. (SOC) a leading private telemedicine company ... has completed the expansion of its senior management ... fastest growing provider of telemedical consultations to hospital ...
... a Champion for BabiesNEW YORK, Feb. 19 The March of ... MVP, Eli Manning , will return for a second year, ... Manning will be joined by CBS 2 News Co-Anchor, Maurice ... , who will co-host the morning program. "I,m very excited to ...
Cached Medicine News:Health News:Dallas Scientists Discover Statins May Falsely Indicate Thyroid Problems 2Health News:Out-of-Control Blood Sugar May Affect Memory 2Health News:IlluminOss Announces First Human Case Utilizing Its Innovative Photodynamic Bone Stabilization System Technology 2Health News:IlluminOss Announces First Human Case Utilizing Its Innovative Photodynamic Bone Stabilization System Technology 3Health News:Pet Owners Avoid a Tax on Their Pet's Health Care in California's Budget 2Health News:Pet Owners Avoid a Tax on Their Pet's Health Care in California's Budget 3Health News:Specialists On Call Expands Senior Management & Sales Teams 2Health News:Eli Manning to Lead March for Babies(R) in Manhattan 2
(Date:7/28/2014)... , SINGAPORE, and TOKYO , July 28, ... it has appointed Roger Crystal , MD as ... served in the Global Business Development Product Acquisition & ... "Roger,s experience in developing business strategy and partnerships in ... we continue to partner with biotechnology and pharmaceutical companies ...
(Date:7/28/2014)... 2014  ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ... its second quarter and year-to-date 2014 financial results on ... U.S. financial markets. The earnings press release will be ... website, www.anipharmaceuticals.com . Arthur S. ... Charlotte C. Arnold , Vice President and Chief Financial ...
(Date:7/28/2014)... 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... Financial Results and Highlights Conference CallWhen:Monday, August 4 at ... How:Live on the Internet. Simply log onto our website ... the live event, a replay of the webcast will ... . ABOUT ISIS PHARMACEUTICALS, INC. Isis is ...
Breaking Medicine Technology:ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 2
... AdvaMed 2011: The MedTech Conference -- day ... Abbott, Abiomed, B. Braun Medical, Baxter International Inc., ... MIT MEDRC in Innovation Alley, a showcase of ... sector meet-ups focused on orthopedic, wound management and ...
... 2011 Tengion, Inc. (Nasdaq: TNGN ) today ... its Board of Directors. Mr. Flora brings to Tengion more ... healing and surgical device businesses.  He most recently served as ... Tengion also announced today that Gary Kurtzman, M.D., ...
Cached Medicine Technology:AdvaMed 2011: The MedTech Conference Closing Day Features Life Changing Innovation, Policymaker Addresses 2Tengion Appoints Scott Flora to Board of Directors 2Tengion Appoints Scott Flora to Board of Directors 3Tengion Appoints Scott Flora to Board of Directors 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: